Avanafil

Avanafil, a phosphodiesterase 5 (PDE5) inhibitor, is a research project transferred by Vivus from Tanabe Mitsubishi Pharmaceuticals, Japan. Used to treat erectile dysfunction (ED) in men. English name: Avanafil, molecular formula: C23H26ClN7O3, molecular weight: 483.9506, density: 1.373g/cm3, CAS number: 330784-47-9.

Chinese name: Avanafil.

Chinese alias: 4 - [(4 - methoxy 3 - chloro - benzyl) amino] - 2 - [2 - (hydroxymethyl) - 1 - pyrrole alkyl] - N - (2 - pyrimidine base methyl) - 5 - pyrimidine a sulfonamide

English alias: 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide ; (S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine; 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carbo xamide

CAS no. : 330784-47-9

Molecular formula: C23H26ClN7O3

Molecular weight: 483.9506